| Adenine | hsa00010 | Glycolysis / Gluconeogenesis | 4.41E-02 | 4 | P04075, P06733, P04406, P60174 | ALDOA, ENO1, GAPDH, TPI1 | More | |
| Adenine | hsa00051 | Fructose and mannose metabolism | 2.21E-02 | 3 | O14772, P60174, P04075 | FPGT, TPI1, ALDOA | More | |
| Adenine | hsa00052 | Galactose metabolism | 2.33E-03 | 2 | P06280, O43451 | GLA, MGAM | More | |
| Adenine | hsa00190 | Oxidative phosphorylation | 2.21E-02 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | |
| Adenine | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | |
| Adenine | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | |
| Adenine | hsa00500 | Starch and sucrose metabolism | 6.17E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Adenine | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | |
| Adenine | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | |
| Adenine | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | |
| Adenine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.62E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | |
| Adenine | hsa00730 | Thiamine metabolism | 5.68E-04 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Adenine | hsa00830 | Retinol metabolism | 1.08E-02 | 3 | Q9BPW9, O75911, P11712 | DHRS9, DHRS3, CYP2C9 | More | |
| Adenine | hsa01200 | Carbon metabolism | 5.71E-03 | 7 | P04075, P04406, P60174, P06733, O14521, Q9P2R7, Q02252 | ALDOA, GAPDH, TPI1, ENO1, SDHD, SUCLA2, ALDH6A1 | More | |
| Adenine | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | |
| Adenine | hsa01230 | Biosynthesis of amino acids | 9.38E-03 | 5 | P60174, P04406, P06733, P04075, Q99707 | TPI1, GAPDH, ENO1, ALDOA, MTR | More | |
| Adenine | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | |
| Adenine | hsa03040 | Spliceosome | 4.48E-04 | 10 | Q14562, O43143, O60508, P17844, P51991, P61978, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, HNRPA3, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8 | More | |
| Adenine | hsa04014 | Ras signaling pathway | 8.66E-03 | 7 | Q9NRA1, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PDGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | |
| Adenine | hsa04062 | Chemokine signaling pathway | 1.59E-03 | 9 | P07948, P19174, P62873, P63218, P50151, Q13009, P14598, P42224, P25963 | LYN, PLCG1, GNB1, GNG5, GNG10, TIAM1, NCF1, STAT1, NFKBIA | More | |
| Adenine | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | |
| Adenine | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | |
| Adenine | hsa04141 | Protein processing in endoplasmic reticulum | 7.41E-06 | 14 | P18848, P30101, P07384, O95487, Q15437, P60604, Q99941, P11142, P07900, P08238, Q9NR31, O95816, Q9H173, Q9UNL2 | ATF4, PDIA3, CAPN1, SEC24B, SEC23B, UBE2G2, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A, BAG2, SIL1, SSR3 | More | |
| Adenine | hsa04145 | Phagosome | 9.18E-04 | 9 | P11215, P60709, Q15075, Q15080, P14598, Q71U36, Q13509, P68371, Q13488 | ITGAM, ACTB, EEA1, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1 | More | |
| Adenine | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | |
| Adenine | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Adenine | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | |
| Adenine | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | |
| Adenine | hsa04371 | Apelin signaling pathway | 7.95E-04 | 7 | P62873, P63218, P50151, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD3, CALM1 | More | |
| Adenine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | |
| Adenine | hsa04530 | Tight junction | 2.08E-02 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | |
| Adenine | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | |
| Adenine | hsa04623 | Cytosolic DNA-sensing pathway | 2.59E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | |
| Adenine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | |
| Adenine | hsa04640 | Hematopoietic cell lineage | 4.95E-02 | 3 | P01730, P06127, P09564 | CD4, CD5, CD7 | More | |
| Adenine | hsa04657 | IL-17 signaling pathway | 1.36E-02 | 5 | O00463, Q16539, P49841, P14780, P01375 | TRAF5, MAPK14, GSK3B, MMP9, TNF | More | |
| Adenine | hsa04659 | Th17 cell differentiation | 1.11E-02 | 6 | P25963, P19174, P42224, P14784, P84022, P08238 | NFKBIA, PLCG1, STAT1, IL2RB, SMAD3, HSP90AB1 | More | |
| Adenine | hsa04664 | Fc epsilon RI signaling pathway | 7.09E-04 | 7 | P01375, P04141, Q16539, Q9UQC2, P07948, P19174, P09917 | TNF, CSF2, MAPK14, GAB2, LYN, PLCG1, ALOX5 | More | |
| Adenine | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | |
| Adenine | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | |
| Adenine | hsa04714 | Thermogenesis | 9.85E-04 | 7 | P15336, P51828, P63261, P62753, Q9Y478, P12074, O15239 | ATF2, ADCY7, ACTG1, RPS6, PRKAB1, COX6A1, NDUFA1 | More | |
| Adenine | hsa04724 | Glutamatergic synapse | 1.57E-02 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
| Adenine | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | |
| Adenine | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | |
| Adenine | hsa04727 | GABAergic synapse | 4.18E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
| Adenine | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | |
| Adenine | hsa04730 | Long-term depression | 4.86E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | |
| Adenine | hsa04744 | Phototransduction | 9.21E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
| Adenine | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | |
| Adenine | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | |
| Adenine | hsa04915 | Estrogen signaling pathway | 2.75E-03 | 5 | Q99941, P18848, P51828, P07900, P11142 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | |
| Adenine | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | |
| Adenine | hsa04920 | Adipocytokine signaling pathway | 2.80E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
| Adenine | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | |
| Adenine | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | |
| Adenine | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | |
| Adenine | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Adenine | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | |
| Adenine | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Adenine | hsa05012 | Parkinson disease | 1.77E-02 | 6 | P60604, P19174, P0DP23, Q71U36, Q13509, P68371 | UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3, TUBB2C | More | |
| Adenine | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | |
| Adenine | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | |
| Adenine | hsa05032 | Morphine addiction | 2.18E-02 | 4 | P62873, P63218, P50151, Q13370 | GNB1, GNG5, GNG10, PDE3B | More | |
| Adenine | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | |
| Adenine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 8.38E-04 | 7 | Q16539, P25963, Q13488, P19174, P25024, P25025, P07948 | MAPK14, NFKBIA, TCIRG1, PLCG1, CXCR1, CXCR2, LYN | More | |
| Adenine | hsa05130 | Pathogenic Escherichia coli infection | 1.44E-03 | 10 | Q71U36, P16333, Q92974, Q13509, P68371, P63261, Q14344, P25963, Q06124, O95487 | TUBA1A, NCK1, ARHGEF2, TUBB3, TUBB2C, ACTG1, GNA13, NFKBIA, PTPN11, SEC24B | More | |
| Adenine | hsa05132 | Salmonella infection | 2.75E-02 | 7 | P25963, P08238, O75369, Q71U36, Q13509, P68371, P49754 | NFKBIA, HSP90AB1, FLNB, TUBA1A, TUBB3, TUBB2C, VPS41 | More | |
| Adenine | hsa05134 | Legionellosis | 4.75E-02 | 3 | P25963, P11215, P11142 | NFKBIA, ITGAM, HSPA8 | More | |
| Adenine | hsa05140 | Leishmaniasis | 5.98E-03 | 6 | P14598, P11215, P42224, P25963, P29350, Q15080 | NCF1, ITGAM, STAT1, NFKBIA, PTPN6, NCF4 | More | |
| Adenine | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | |
| Adenine | hsa05163 | Human cytomegalovirus infection | 2.50E-04 | 14 | P01375, P25963, P62873, P63218, P50151, P0DP23, Q14344, P49841, P14778, P25025, Q16539, O00463, P30101, P01568 | TNF, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3, IFNA21 | More | |
| Adenine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.62E-05 | 10 | P01568, P42224, P25963, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | |
| Adenine | hsa05168 | Herpes simplex virus 1 infection | 3.79E-02 | 9 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, ZNF211, ZNF189 | More | |
| Adenine | hsa05170 | Human immunodeficiency virus 1 infection | 1.19E-02 | 8 | P62873, P63218, P50151, P0DP23, P30101, P01568, P25963, P19174 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, NFKBIA, PLCG1 | More | |
| Adenine | hsa05200 | Pathways in cancer | 1.99E-03 | 15 | P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | |
| Adenine | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | |
| Adenine | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | |
| Adenine | hsa05212 | Pancreatic cancer | 4.75E-02 | 3 | P42224, P84022, O75293 | STAT1, SMAD3, GADD45B | More | |
| Adenine | hsa05214 | Glioma | 4.75E-02 | 3 | P0DP23, P19174, O75293 | CALM1, PLCG1, GADD45B | More | |
| Adenine | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | |
| Adenine | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | |
| Adenine | hsa05415 | Diabetic cardiomyopathy | 3.94E-02 | 6 | P17252, P14598, Q15080, Q16718, O14521, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, GAPDH | More | |
| Adenine | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | |
| Flavin-adenine-dinucleotide | hsa00071 | Fatty acid degradation | 2.45E-02 | 3 | P11310, P28332, P33121 | ACADM, ADH6, ACSL1 | More | |
| Flavin-adenine-dinucleotide | hsa00220 | Arginine biosynthesis | 3.96E-04 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | |
| Flavin-adenine-dinucleotide | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.48E-04 | 2 | Q96RQ9, P15104 | IL4I1, GLUL | More | |
| Flavin-adenine-dinucleotide | hsa00270 | Cysteine and methionine metabolism | 4.90E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00280 | Valine, leucine and isoleucine degradation | 3.29E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00350 | Tyrosine metabolism | 3.29E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00360 | Phenylalanine metabolism | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00380 | Tryptophan metabolism | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00400 | Phenylalanine, tyrosine and tryptophan biosynthesis | 1.66E-02 | 1 | Q96RQ9 | IL4I1 | More | |
| Flavin-adenine-dinucleotide | hsa00830 | Retinol metabolism | 3.15E-02 | 1 | P00325 | ADH1B | More | |
| Flavin-adenine-dinucleotide | hsa00910 | Nitrogen metabolism | 1.66E-02 | 1 | P15104 | GLUL | More | |
| Flavin-adenine-dinucleotide | hsa01200 | Carbon metabolism | 4.29E-02 | 4 | P04406, O14521, Q9P2R7, Q02252 | GAPDH, SDHD, SUCLA2, ALDH6A1 | More | |
| Flavin-adenine-dinucleotide | hsa03020 | RNA polymerase | 1.31E-02 | 2 | P24928, P62487 | POLR2A, POLR2G | More | |
| Flavin-adenine-dinucleotide | hsa04020 | Calcium signaling pathway | 2.63E-02 | 2 | P05141, P63092 | SLC25A5, GNAS | More | |
| Flavin-adenine-dinucleotide | hsa04217 | Necroptosis | 4.39E-02 | 2 | Q12933, P15104 | TRAF2, GLUL | More | |
| Flavin-adenine-dinucleotide | hsa04270 | Vascular smooth muscle contraction | 2.03E-02 | 2 | P63092, P35579 | GNAS, MYH9 | More | |
| Flavin-adenine-dinucleotide | hsa04390 | Hippo signaling pathway | 2.40E-02 | 2 | P35240, Q92796 | NF2, DLG3 | More | |
| Flavin-adenine-dinucleotide | hsa04612 | Antigen processing and presentation | 8.21E-03 | 5 | P26715, P26717, Q07444, Q13241, P01732 | KLRC1, KLRC2, KLRC3, KLRD1, CD8A | More | |
| Flavin-adenine-dinucleotide | hsa04622 | RIG-I-like receptor signaling pathway | 4.90E-02 | 1 | Q12933 | TRAF2 | More | |
| Flavin-adenine-dinucleotide | hsa04650 | Natural killer cell mediated cytotoxicity | 8.48E-05 | 8 | P06239, P20963, Q13241, P26718, O14931, P26717, Q07444, P26715 | LCK, CD247, KLRD1, KLRK1, NCR3, KLRC2, KLRC3, KLRC1 | More | |
| Flavin-adenine-dinucleotide | hsa04658 | Th1 and Th2 cell differentiation | 7.09E-05 | 7 | Q04759, P20963, P09693, P06239, P23771, Q9UL17, Q13761 | PRKCQ, CD247, CD3G, LCK, GATA3, TBX21, RUNX3 | More | |
| Flavin-adenine-dinucleotide | hsa04659 | Th17 cell differentiation | 2.34E-03 | 6 | Q04759, P06239, Q9UL17, P23771, P09693, P20963 | PRKCQ, LCK, TBX21, GATA3, CD3G, CD247 | More | |
| Flavin-adenine-dinucleotide | hsa04660 | T cell receptor signaling pathway | 8.49E-04 | 7 | Q04759, O95267, Q08881, P20963, P09693, P01732, P06239 | PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, LCK | More | |
| Flavin-adenine-dinucleotide | hsa04972 | Pancreatic secretion | 1.31E-02 | 2 | Q08828, P62491 | ADCY1, RAB11A | More | |
| Flavin-adenine-dinucleotide | hsa04974 | Protein digestion and absorption | 1.52E-02 | 1 | P02452 | COL1A1 | More | |
| Flavin-adenine-dinucleotide | hsa05146 | Amoebiasis | 2.73E-02 | 4 | P09341, P05089, P12814, P08311 | CXCL1, ARG1, ACTN1, CTSG | More | |
| Flavin-adenine-dinucleotide | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.88E-03 | 5 | O95267, P20963, P09693, P06239, Q04759 | RASGRP1, CD247, CD3G, LCK, PRKCQ | More | |
| Flavin-adenine-dinucleotide | hsa05322 | Systemic lupus erythematosus | 1.57E-02 | 4 | P08311, P62807, Q16778, P12814 | CTSG, HIST1H2BC, HIST2H2BE, ACTN1 | More | |
